Vericel Stock

Vericel Net Margin

The Net Profit Margin of Vericel (VCEL) as of Aug 16, 2026 is 5.98 %. In the previous year, Net Profit Margin was 4.37 % — a change of 36.89% (higher).

Net Margin

5.98 %

YoY

36.89%

Last updated:

Net Profit Margin of Vericel is 2026 5.98 % . Net Profit Margin of Vericel was 2025 4.37 % . It decreases by 36.89% higher compared to the previous year.

For Vericel, the net margin of 6.0% is up versus -4.8% a few years ago.

Access this data via the Eulerpool API

Vericel Stock analysis

What does Vericel do? Vericel Corp is a US biotechnology company specializing in the development and commercialization of innovative cell therapies for patients with serious diseases. The company is headquartered in Cambridge, Massachusetts and was founded in 1997. Vericel is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Vericel stock

Net Profit Margin of Vericel is 5.98 % in 2026.

Net Profit Margin of Vericel changed from 4.37 % to 5.98 %, representing a 36.89% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Net Profit Margin Vericel since 2006 – with annual values, charts, and detailed analysis.

Net Margin measures the percentage of revenue that becomes net profit after all expenses. It is the ultimate measure of a company's profitability.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Net Profit Margin's Vericel with sector peers and the industry average to assess whether it is attractive.

To evaluate Net Profit Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Net Profit Margin.

Access this data via the Eulerpool API

Margins — Vericel

All Key Metrics — Vericel